‘Responsive, professional, and practical’, Advestra is trusted by an array of clients with corporate and M&A work, particularly in the TMT sector. Thomas Reutter's strengths lie in M&A transactions, while Daniel Raun contributes his expertise in a range of corporate transactions to the practice. Beda Kaufmann is extremely well versed in M&A and private equity transactions. The firm’s offering was also strengthened by the arrival of private equity and venture capital expert Andreas Hinsen from Loyens & Loeff in February 2023.
Testimonials
Collated independently by Legal 500 research team.
‘Pragmatic, efficient, fast.’
‘Andreas Hinsen was remarkably responsive. He collaborated effectively with co-counsel, and presented effectively to our board and other outside advisors.’
‘Andreas Hinsen was exceptionally responsive and engaging. He was also a good listener who sought to understand the issues presented, and who sought to understand the priorities which were important to our company.’
‘The Advestra team was responsive, professional, and practical in providing legal advice. We collaborated on a tricky, unique case and they provided strong options that ultimately resulted in a positive outcome.’
'Friendly, very accessible, true partners.'
'Always available and reply quickly to queries. Able to co-ordinate a project with various parties.'
'Pragmatic and look for solutions rather than problems.'
'Andreas Hinson was a significant influence on the positive outcome of our project, and his sound understanding of our options, combined with practical ideas, led to success. He has strong communication skills and is responsive, professional and diligent.'
Key clients
- Ironwood Pharmaceuticals, Inc
- Ardian
- Catalyst Pharmaceuticals
- UBS
- Morgan Stanley
- Altor Funds
- Shift4 Payments Inc.
- Founders of GEM Consulting
- Shareholders of PANOLIN
Work highlights
- Advised private investment house Ardian on its investment in Swiss Flowable Holding AG and its subsidiaries.
- Advised Ironwood Pharmaceuticals on the cash tender offer for VectivBio.
- Advised Catalyst Pharmaceuticals on the licence for vamorolone and its equity investment in Santhera Pharmaceuticals.